Prudential Financial’s G1 Therapeutics GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-20,440
Closed -$46.6K – 2821
2024
Q2
$46.6K Buy
20,440
+4,840
+31% +$18.5K ﹤0.01% 2617
2024
Q1
$67.4K Sell
15,600
-2,800
-15% -$9.8K ﹤0.01% 2568
2023
Q4
$56.1K Sell
18,400
-2,600
-12% -$4.88K ﹤0.01% 2542
2023
Q3
$30.2K Buy
21,000
+4,800
+30% +$9.29K ﹤0.01% 2547
2023
Q2
$40.3K Buy
+16,200
New +$44.3K ﹤0.01% 2554

Prudential Financial's GTHX Position: Q3 2024 in Review

Prudential Financial sold out of G1 Therapeutics (GTHX) in Q3 2024, closing a stake of 20,440 shares — an estimated $46.6K sold.

Prudential Financial first reported a position in GTHX in Q2 2023 and held it in 5 quarters. The position peaked at $67.4K in Q1 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Prudential Financial reported no remaining G1 Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Prudential Financial sold 20,440 G1 Therapeutics shares in Q3 2024, an estimated $46.6K.
  • Prudential Financial first reported a position in G1 Therapeutics in Q2 2023 and held it in 5 quarters.
  • Prudential Financial's G1 Therapeutics position peaked at $67.4K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.